Jackson Creek Investment Advisors LLC Aurinia Pharmaceuticals Inc. Transaction History

Jackson Creek Investment Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 05, 2024	SELL	$7.13 - $9.49 $149 - $199	-21 Reduced 0.02%	97,492 $876,000
Q3 2023 Nov 03, 2023	SELL	$7.77 - $12.27 $536 - $846	-69 Reduced 0.07%	97,513 $758,000
Q2 2023 Aug 02, 2023	BUY	$8.96 - $11.69 $53,303 - $69,543	5,949 Added 6.49%	97,582 $945,000
Q1 2023 May 02, 2023	BUY	$5.94 - $11.27 $544,300 - $1.03 Million	91,633 New	91,633 $1 Million

208

58.1M

1.14M

1.51M

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.14B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

Get notified when there are updates to the investment portfolio of Jackson Creek Investment Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Jackson Creek Investment Advisors LLC with notifications on news.